IL32, interleukin 32, 9235

N. diseases: 200; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE This emphasizes on unrecognized role of IL-32 in biology of diffuse type of gastric cancer. 30402092 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE There have been few studies concerning the cytokine profiles in gastric mucosa of Helicobacter pylori-infected patients with normal mucosa, chronic gastritis, and gastric carcinoma (GAC).In the present study, we aimed to elucidate the genomic expression levels and immune pathological roles of cytokines-interferon (IFN)-γ, tumor necrosis factor (TNF)-α, interleukin (IL)-4, IL-6, IL-10, transforming growth factor (TGF)-β, IL-17A, IL-32-in H pylori-infected patients with normal gastric mucosa (NGM; control), chronic active gastritis (CAG), and GAC. 27196487 2016
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 GeneticVariation disease BEFREE Stratified analysis indicated that risks of GC and its precursors were elevated in subjects with IL-32 rs2015620 A allele (AA + AT) or IL-22 rs1179251 CC genotype and H. pylori infection, and significant interactions between these two SNPs and H. pylori infection were found. 26358252 2016
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE IL-32 contributes to gastric cancer progression by increasing the metastatic potential resulting from AKT, β-catenin, and HIF-1α activation. 24602839 2014
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE Multivariate analysis demonstrated that IL-32 is one of the prognostic markers (p < 0.03) for gastric cancer, in addition to nodal involvement and tumor depth. 23479179 2013
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE Levels of interleukin-32 (IL-32), a recently described inflammatory cytokine, are increased in various inflammatory diseases, such as rheumatoid arthritis and Crohn's disease, and in malignancies, including gastric cancer. 22890997 2012
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.070 Biomarker disease BEFREE Therefore, the current study investigates whether adenoviral vector-mediated NK4 gene therapy has therapeutic potential for gastric cancer. 15026993 2004